Press "Enter" to skip to content

Column: 'It feels like a second-class shot.' Johnson & Johnson's vaccine equity problem

The COVID-19 vaccine from Johnson & Johnson will save lives. But public health officials must address the false narrative that it’s a lesser vaccine.


Source: Los Angeles Times

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *